Research, partnerships and case studies

Cedars-Sinai Medical Center and health technology company Solu announce today a partnership to study and understand hospital-acquired infections from an epidemiological and antibiotic resistance perspective. Solu offers an end-to-end service that provides insight into the causes of antibiotic resistance and whether the infection is hospital-acquired.

You can now view the most comprehensive dataset of 100 diverse Acinetobacter baumannii genomes directly on Solu!

Follow a genomic investigation into a Shiga toxin producing E.coli outbreak

The emerging fungal pathogen Candida auris is a growing public health threat due to its fast spread, multidrug-resistance, high transmissibility, and high mortality rates. We created a free web application called candida.app for fast and easy genomic characterization of C.auris isolates.

Salmonella Typhi is a bacterial pathogen that causes typhoid fever, a serious illness affecting millions of people worldwide. In this case study, we will explore the use of the Solu platform to investigate a Salmonella Typhi outbreak and analyze the genomic data associated with it.

Candida auris is an emerging health threat, and better genomic analysis tool are needed for its surveillance. Candida.app is a free, user-friendly tool for genomic analysis of C. auris isolates. This validation study shows that Solu and candida.app are accurate for genomıc characterization of Candida auris.